Scientific Formulation
Defshot
Rapid-onset glucocorticoid therapy. Defshot is engineered to provide faster anti-inflammatory action (1.3 hrs) compared to conventional steroids, ensuring maximum efficacy with a superior safety profile.
Molecular Composition
Deflazacort 6 mg / 12 mg Tablet
Therapeutic Matrix
- 1.3 Hour Rapid Onset
- Superior to Methylprednisolone
- Well-Tolerated Molecule
- Auto-Immune Support
Mechanisms of Action
Deflazacort
Provides a potency ratio of 0.69 to 0.89 against prednisolone, delivering effective anti-inflammatory control with significantly fewer metabolic side effects.
Clinical Advantage
Faster clinical action than Prednisolone (1.6 hr) and Methylprednisolone (2.7 hr), making it the preferred choice for acute and chronic inflammatory conditions.
Precision Healthcare for Everyone
